This is a randomized controlled trial evaluating the impact of the mobile phone delivered SVS SET Program on utilization, functional capacity, symptoms and quality of life.
This is a national randomized controlled study with approximately 10-15 sites enrolling patients with Rutherford II peripheral artery disease (PAD) in total. Patients will be randomized between the SVS SET Program and "usual care" for each site. The primary outcome will be to study the site-specific effect on utilization of exercise therapy. Secondary outcomes will be the effect on the 6-minute-walk test, passive activity and quality of life.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
This is a health coach driven exercise prescription for patients recommending 30 minutes or more of moderate effort walking 3-5 days a week with expected walk-rest-walk-rest intervals.
Number of Participants Who Complete a 12-week Exercise Therapy Program
Completion of a 12-week program in the treatment group will be completion of the remote SVS SET Program while the "usual care" group may have an in-person 12-week exercise therapy program.
Time frame: 12 weeks.
Mobile Phone Delivered 6-Minute Walk Test
Mobile-phone delivered 6-minute walk test result in steps to be reported at three time points.
Time frame: Weeks 0, 6 and 12
Passive Activity as Measured on Mobile Device
Daily passive step count activity as measured by sensors in mobile phone.
Time frame: 12 weeks.
Quality of Life Survey as measured by the mini-Walking Impairment Questionnaire (mini-WIQ)
QoL questionnaires will be asked on the mobile phone at three time points.
Time frame: Weeks 1, 6, and 12
Adherence as Measured by Completion of Scheduled Daily Walks
Adherence to the recommended exercise therapy frequency (3 walks per week) and duration (for at least 30 minutes or more) will be measured
Time frame: 12 weeks.
Freedom From Intervention as Measured by Absence of Surgical Intervention at One Year
Freedom from any surgical intervention will be reported at one year by performing a chart review.
Time frame: 1 year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.